Track the Syra Health Corp share price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €10.4m. The latest transaction was disclosed on 3 February 2026 (Attribution). Among the most active insiders: Allam Sandeep. Every trade is openly available.
13
Insider Decl.
n/a
Thresholds
€8,799
12 ops.
Buy Volume
n/a
n/a
Sell Volume
49Σ signal
Buys €8,799n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,637 of 29,057 companies
23.8
score / 100
Value
20
Quality
27
FCF yld-4.3%
Earn yld-8.7%
EV/EBITDA·
ROE-7.6%
Gross mgn34%
Net mgn-12%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
294 shares@ US$1.317.7% of flowClass A Common StockSEC:0001493152-23-046134:8
Canonical exit: 13 Mar 2024 (T+90)
13 of 13 declarations
About Syra Health Corp
Syra Health Corp is a company listed on the XNAS market, specializing in the healthcare sector. It focuses on developing innovative solutions to enhance healthcare services.